MHRA reprimands two manufacturers over advertisements
Schering-Plough and Servier have been admonished by the Medicines and Healthcare products Regulatory Agency over misleading advertisements.
Schering-Plough agreed to amend an advertisement for Nasonex Nasal Spray
(published in the BMJ on 2 June). The advertisement claimed: “Compared
to fluticasone propionate patients prefer alcohol-free Nasonex … ” However,
this was supported by evidence only on the product’s physical properties
of scent, taste and aftertaste.
Servier has agreed to withdraw an advertisement for Procoralan (ivabradine),
published in the BMJ on 16 June. The advertisement was considered misleading
because it implied that Procoralan was superior to beta-blockers and
did not reflect the licensed indication for Procoralan, which is used
for patients who have a contraindication to or intolerance for beta-blockers.
The MHRA also reports this week that complaints it made to the Advertising
Standards Authority about the Everwell Chinese Medicine Centre (in Maidstone,
Kent) have been upheld. The company was advertising traditional Chinese
medicines and making inaccurate and misleading medicinal claims.
|
The
Pharmaceutical Journal
Acrobat
Reader